Sign up Australia
Proactive Investors - Run By Investors For Investors

Altech Chemicals finalises US$190 million finance package for Alumina plant

Altech is exploring potential project-level joint venture options.
Picture of cash
Project funding that adds shareholder value and minimises dilution is the key goal

Altech Chemicals Ltd (ASX:ATC) (FRA:A3Y) has formalised a total debt package of US$190 million for its proposed Malaysian high purity alumina (HPA) project.

HPA is a high-value, high margin product used in the manufacture of products such as substrates for LED lights and a range of other high growth industries.

The financing consists of a US$170 million debt package negotiated with the German export credit agency (ECA), with the balance of US$20 million at normal commercial terms.

The ECA covered loan (US$170 million) is for an extended period with highly attractive terms, providing Altech with ample time to build the plant and bring it into production.

Increased clarity surrounding funding has generated interest in the HPA project.

READ: Altech Chemicals sees heightened interest in its alumina project in Malaysia

Remaining funding covers two-year construction period

The balance of US$20 million of borrowing will be a 7-year loan including a 2-year construction period, resulting in a 5-year repayment period and at customary lending terms.

Iggy Tan, managing director, said: “By comparison to typical project finance, the project finance agreed with KfW IPEX-Bank is extremely attractive.

The final step to finance close is the execution of the facility agreement documentation and the satisfaction of various conditions precedent required before first debt draw-down.”

Altech considers final funding options

Altech’s objective is to achieve a robust project funding solution that maximises shareholder returns and minimises dilution

The company has commenced the project equity funding process, which is a condition precedent to debt draw-down.

The required equity component of project funding will be determined as management works though the balance of funding options and financing costs.

The final funding mix may include subordinated mezzanine finance and/or project level equity participation.

A joint venture could be considered

Since the KfW IPEX-Bank debt funding was confirmed in late 2017, there has been heightened interest in Altech and its HPA project.

This has resulted in a number of project funding options being presented.

Altech is also exploring potential project-level joint venture options with several major industrial groups.

This could result in a major reduction of the equity funding required to fund the project and subordinated mezzanine finance with associated equity. 

View full ATC profile View Profile

Altech Chemicals Ltd Timeline

Related Articles

itaconix.jpg
January 05 2018
"Our objective is to continue to drive product revenue starts and growth," the company said
Altech Chemicals' Iggy Tan with investors at Proactive's CEO Sessions
October 06 2017
Iggy Tan discussed the company at Proactive's CEO Sessions.
molecular makeup of graphene
August 23 2017
Its shares, up 16% in the year to date, nudged a further 5% higher Tuesday after it unveiled an outline agreement with Rogers Advanced Composites

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use